Page 1 of Clinical Trials for "Reverse Transcriptase Inhibitors", 1312 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects
Last Updated: February 3, 2012
Condition(s): Human Immunodeficiency Virus Infections
2
Not yet recruiting
CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy
Last Updated: April 6, 2009
Condition(s): HIV Infections
3
Completed
Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects
Last Updated: April 7, 2011
Condition(s): Human Immunodeficiency Virus Infections
4
Completed
Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Last Updated: September 27, 2011
Condition(s): HIV Infections
5
Terminated
Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
Last Updated: November 14, 2005
Condition(s): HIV Infections; HIV Lipodystrophy Syndrome
6
Completed
Drug-Drug Interaction (DDI) H2 Antagonists
Last Updated: November 29, 2011
Condition(s): HIV
7
Terminated
Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
Last Updated: November 14, 2005
Condition(s): HIV Infections; HIV-Associated Lipodystrophy Syndrome
8
Active, not recruiting
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
Last Updated: June 23, 2005
Condition(s): HIV Infections
9
Completed
A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
Last Updated: June 23, 2005
Condition(s): HIV Infections
10
Completed
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
Last Updated: June 23, 2005
Condition(s): HIV Infections
11
Completed
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
Last Updated: April 2, 2008
Condition(s): HIV Infections
12
Completed
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
Last Updated: June 23, 2005
Condition(s): HIV Infections
13
Completed
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
Last Updated: June 23, 2005
Condition(s): HIV Infections
14
Completed
Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Last Updated: February 26, 2008
Condition(s): HIV Infections
15
Completed
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Last Updated: April 26, 2011
Condition(s): HIV Infection; HIV; Acquired Immunodeficiency Syndrome
16
Completed
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
Last Updated: June 23, 2005
Condition(s): HIV Infections
17
Recruiting
Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Last Updated: March 23, 2012
Condition(s): Acquired Immunodeficiency Syndrome; HIV Infections
18
Completed
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
Last Updated: June 23, 2005
Condition(s): HIV Infections
19
Recruiting
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Last Updated: February 5, 2009
Condition(s): HIV Infections; Hepatitis C
20
Withdrawn
Raltegravir Activity In Lymphoid Tissues
Last Updated: October 24, 2011
Condition(s): HIV Infection; HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Reverse+Transcriptase+Inhibitors%22

Page 1 of Clinical Trials for "Reverse Transcriptase Inhibitors", 1312 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About